CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
CorMedix Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$7.38+0.12 (+1.65%)
Close on Oct 19, 2026
- Market cap
- $682.50M
- P/E (TTM)
- 3.6
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
56.5%
44M of 78M shares
Institutional holders
194
30 new, 21 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
1 buys · 8 sales
Net sold $2.37M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 6,274,076 | 7.94% | 13G (passive) amendment | Mar 31, 2026 |
| Shaibatalhamd Aymen Abdalkader | 4,618,511 | 5.90% | 13G (passive) amendment | Jun 11, 2026 |
| BlackRock, Inc. | 4,567,897 | 7.50% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,324,111 | 8.11% | $49.64M | +356,536 | 0.00% |
| Deep Track Capital, LP | 6,274,076 | 8.05% | $49.25M | – | 0.72% |
| Vanguard Capital Management LLC | 3,135,075 | 4.02% | $24.61M | +5,419 | 0.00% |
| State Street Corp | 2,316,845 | 2.97% | $18.19M | +125,002 | 0.00% |
| Royce & Associates LP | 2,176,362 | 2.79% | $17.08M | +288,830 | 0.14% |
| Geode Capital Management, LLC | 1,947,014 | 2.50% | $15.29M | +130,107 | 0.00% |
| UBS Group AG | 1,877,940 | 2.41% | $14.74M | +339,695 | 0.00% |
| Oberweis Asset Management Inc/ | 1,323,915 | 1.70% | $10.39M | +112,800 | 0.21% |
| Alyeska Investment Group, L.P. | 850,000 | 1.09% | $6.67M | – | 0.02% |
| Marshall Wace, Llp | 779,535 | 1.00% | $6.12M | +276,570 | 0.00% |
| Northern Trust Corp | 756,430 | 0.97% | $5.94M | +118,747 | 0.00% |
| Vanguard Portfolio Management LLC | 708,604 | 0.91% | $5.56M | −33,967 | 0.00% |
| Pacer Advisors, Inc. | 633,978 | 0.81% | $4.98K | +53,358 | 0.01% |
| Hrt Financial LP | 625,558 | 0.80% | $4.91K | +333,113 | 0.00% |
| Trexquant Investment LP | 623,797 | 0.80% | $4.90M | +63,160 | 0.03% |
| Charles Schwab Investment Management Inc | 618,172 | 0.79% | $4.85M | +15,206 | 0.00% |
| Armistice Capital, LLC | 500,000 | 0.64% | $3.93M | New | 0.05% |
| Vanguard Fiduciary Trust Co | 484,322 | 0.62% | $3.80M | −21,357 | 0.00% |
| Goldman Sachs Group Inc | 466,393 | 0.60% | $3.66M | −44,936 | 0.00% |
| Raymond James Financial Inc | 446,142 | 0.57% | $3.50M | +117,918 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 194 | 44M | 56.5% | 30 / 68 | 59 / 21 | 6M | 3M |
| Q1 2026 | 188 | 41M | 52.8% | 44 / 55 | 60 / 49 | 13M | 9M |
| Q4 2025 | 199 | 42M | 53.8% | 39 / 78 | 57 / 28 | 11M | 12M |
| Q3 2025 | 190 | 43M | 55.5% | 51 / 91 | 28 / 33 | 15M | 6M |
| Q2 2025 | 172 | 34M | 44.0% | 52 / 62 | 36 / 14 | 15M | 4M |
| Q1 2025 | 136 | 24M | 30.2% | 27 / 50 | 34 / 17 | 4M | 4M |
| Q4 2024 | 129 | 23M | 29.5% | 40 / 49 | 24 / 11 | 7M | 3M |
| Q3 2024 | 102 | 19M | 24.8% | 19 / 38 | 22 / 15 | 8M | 3M |
| Q2 2024 | 99 | 17M | 22.0% | 18 / 37 | 22 / 9 | 2M | 2M |
| Q1 2024 | 90 | 18M | 22.7% | 8 / 24 | 33 / 19 | 1M | 2M |
| Q4 2023 | 101 | 19M | 24.4% | 17 / 37 | 20 / 8 | 2M | 1M |
| Q3 2023 | 92 | 18M | 23.0% | 18 / 34 | 21 / 12 | 2M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CRMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,227,723 | 2.86% | $17.49M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,939,160 | 2.49% | $15.22M | 0.02% | Jun 30, 2026 |
| Oberweis Micro-Cap Fund | 1,277,200 | 1.64% | $10.03M | 0.62% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 824,083 | 1.06% | $6.47M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 816,503 | 1.05% | $6.15M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 683,402 | 0.88% | $5.36M | 0.04% | Jun 30, 2026 |
| Pacer US Small Cap Cash Cows 100 ETF | 626,124 | 0.80% | $4.71M | 0.13% | Jul 31, 2026 |
| Royce Small-Cap Opportunity Fund | 566,897 | 0.73% | $4.45M | 0.32% | Jun 30, 2026 |
| Royce Small-Cap Fund | 562,746 | 0.72% | $4.42M | 0.21% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | 549,805 | 0.71% | $4.32M | 1.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 381,249 | 0.49% | $3.22M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 381,233 | 0.49% | $3.22M | 0.02% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 347,750 | 0.45% | $2.94M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 250,705 | 0.32% | $1.97M | 0.13% | Jun 30, 2026 |
| Royce Capital Fund - Small-Cap Portfolio | 245,212 | 0.31% | $1.92M | 1.03% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph Todisco | Chief Executive Officer, Director | 774,749 | 0.99% | Feb 6, 2026 |
| Kaufman Beth Zelnick | Chief Legal Officer | 260,684 | 0.33% | Sep 1, 2026 |
| Elizabeth Hurlburt | Chief Operating Officer | 270,463 | 0.35% | Sep 1, 2026 |
| Susan Blum | Chief Financial Officer | 124,315 | 0.16% | Sep 1, 2026 |
| Michael David Seckler | Chief Commercial Officer | 133,156 | 0.17% | Jan 15, 2026 |
| Matthew T. David | Chief Financial Officer | 95,270 | 0.12% | Jan 14, 2025 |
| Erin Mistry | EVP, Chief Commercial Officer | 100,992 | 0.13% | Jan 14, 2025 |
| Janet Dillione | Director | 117,835 | 0.15% | Sep 18, 2026 |
| Robert A. Stewart | Director | 66,453 | 0.09% | Jan 27, 2026 |
| Myron Kaplan | Director | 261,487 | 0.34% | Jan 27, 2026 |
| Gregory Scott Duncan | Director | 68,786 | 0.09% | Jan 27, 2026 |
| Steven W. Lefkowitz | Director | 158,103 | 0.20% | Jan 27, 2026 |
| Alan W. Dunton | Director | 70,703 | 0.09% | Jan 27, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Janet Dillione Director | Sep 18, 2026 | Option exercise | +48,909 | – | – | 117,835 |
| Susan Blum Chief Financial Officer | Aug 29, 2026 | Tax withholding | −8,424 | $8.30 | $69.92K | 124,315 |
| Elizabeth Hurlburt Chief Operating Officer | Aug 29, 2026 | Tax withholding | −8,076 | $8.30 | $67.03K | 270,463 |
| Kaufman Beth Zelnick Chief Legal Officer | Aug 29, 2026 | Tax withholding | −8,424 | $8.30 | $69.92K | 260,684 |
| Elizabeth Hurlburt Chief Operating Officer | Feb 4, 2026 | Award | +36,006 | – | – | 278,539 |
| Joseph Todisco Chief Executive Officer, Director | Feb 4, 2026 | Award | +77,156 | – | – | 774,749 |
| Kaufman Beth Zelnick Chief Legal Officer | Feb 4, 2026 | Award | +36,006 | – | – | 269,108 |
| Gregory Scott Duncan Director | Jan 26, 2026 | Award | +30,453 | – | – | 68,786 |
| Janet Dillione Director | Jan 26, 2026 | Award | +30,453 | – | – | 68,926 |
| Robert A. Stewart Director | Jan 26, 2026 | Award | +30,453 | – | – | 66,453 |
| Steven W. Lefkowitz Director | Jan 26, 2026 | Award | +30,453 | – | – | 125,951 |
| Alan W. Dunton Director | Jan 26, 2026 | Award | +30,453 | – | – | 70,703 |
| Myron Kaplan Director | Jan 26, 2026 | Award | +30,453 | – | – | 231,487 |
| Elizabeth Hurlburt Chief Operating Officer | Jan 23, 2026 | Award | +93,010 | – | – | 253,311 |
| Elizabeth Hurlburt Chief Operating Officer | Jan 23, 2026 | Tax withholding | −10,778 | $7.27 | $78.36K | 242,533 |
| Susan Blum Chief Financial Officer | Jan 23, 2026 | Award | +72,820 | – | – | 142,506 |
| Susan Blum Chief Financial Officer | Jan 23, 2026 | Tax withholding | −9,767 | $7.27 | $71.01K | 132,739 |
| Joseph Todisco Chief Executive Officer, Director | Jan 23, 2026 | Tax withholding | −27,306 | $7.27 | $198.51K | 697,593 |
| Joseph Todisco Chief Executive Officer, Director | Jan 23, 2026 | Award | +225,900 | – | – | 724,899 |
| Kaufman Beth Zelnick Chief Legal Officer | Jan 23, 2026 | Award | +72,820 | – | – | 241,905 |
| Kaufman Beth Zelnick Chief Legal Officer | Jan 23, 2026 | Tax withholding | −8,803 | $7.27 | $64.00K | 233,102 |
| Janet Dillione Director | Jan 21, 2026 | Sale(10b5-1 plan) | −10,000 | $6.88 | $68.80K | 38,473 |
| Joseph Todisco Chief Executive Officer, Director | Jan 17, 2026 | Tax withholding | −22,665 | $6.78 | $153.67K | 498,999 |
| Joseph Todisco Chief Executive Officer, Director | Jan 16, 2026 | Option exercise | +29,585 | $3.38 | $100.00K | 521,664 |
| Elizabeth Hurlburt Chief Operating Officer | Jan 12, 2026 | Tax withholding | −5,794 | $7.15 | $41.43K | 160,301 |
| Joseph Todisco Chief Executive Officer, Director | Jan 12, 2026 | Tax withholding | −17,417 | $7.15 | $124.53K | 492,079 |
| Steven W. Lefkowitz Director | Jan 12, 2026 | Option exercise | +15,000 | $5.63 | $84.45K | 95,498 |
| Michael David Seckler Chief Commercial Officer | Jan 8, 2026 | Award | +133,156 | – | – | 133,156 |
| Elizabeth Hurlburt Chief Operating Officer | Jan 2, 2026 | Tax withholding | −10,895 | $12.16 | $132.48K | 166,095 |
| Kaufman Beth Zelnick Chief Legal Officer | Jan 2, 2026 | Tax withholding | −11,333 | $12.16 | $137.81K | 169,085 |
| Alan W. Dunton Director | Dec 30, 2025 | Sale(10b5-1 plan) | −20,000 | $13.00 | $260.00K | 40,250 |
| Alan W. Dunton Director | Dec 30, 2025 | Option exercise | +20,000 | $4.03 | $80.60K | 60,250 |
| Joseph Todisco Chief Executive Officer, Director | Dec 18, 2025 | Sale(10b5-1 plan) | −30,000 | $12.00 | $360.00K | 509,496 |
| Joseph Todisco Chief Executive Officer, Director | Dec 18, 2025 | Option exercise | +30,000 | $4.43 | $132.90K | 539,496 |
| Janet Dillione Director | Dec 9, 2025 | Sale(10b5-1 plan) | −34,000 | $12.00 | $408.00K | 48,473 |
| Janet Dillione Director | Dec 9, 2025 | Option exercise | +19,000 | $9.55 | $181.45K | 67,473 |
| Janet Dillione Director | Dec 9, 2025 | Option exercise | +15,000 | $5.63 | $84.45K | 82,473 |
| Steven W. Lefkowitz Director | Dec 9, 2025 | Sale | −40,000 | $11.88 | $475.20K | 80,498 |
| Janet Dillione Director | Dec 2, 2025 | Option exercise | +19,323 | $3.55 | $68.60K | 95,130 |
| Janet Dillione Director | Dec 2, 2025 | Option exercise | +15,124 | $4.43 | $67.00K | 75,807 |
| Janet Dillione Director | Dec 2, 2025 | Option exercise | +12,210 | $4.03 | $49.21K | 60,683 |
| Janet Dillione Director | Dec 2, 2025 | Sale(10b5-1 plan) | −46,657 | $10.00 | $466.57K | 48,473 |
| Janet Dillione Director | Nov 24, 2025 | Sale | −26,343 | $9.93 | $261.59K | 48,473 |
| Janet Dillione Director | Nov 24, 2025 | Option exercise | +8,000 | $2.85 | $22.80K | 56,473 |
| Janet Dillione Director | Nov 24, 2025 | Option exercise | +4,876 | $4.43 | $21.60K | 69,139 |
| Janet Dillione Director | Nov 24, 2025 | Option exercise | +5,677 | $3.55 | $20.15K | 74,816 |
| Janet Dillione Director | Nov 24, 2025 | Option exercise | +7,790 | $4.03 | $31.39K | 64,263 |
| Janet Dillione Director | Nov 14, 2025 | Sale | −30,000 | $11.42 | $342.60K | 48,473 |
| Myron Kaplan Director | Oct 23, 2025 | Buy | +25,000 | $11.02 | $275.50K | 201,034 |
| Gregory Scott Duncan Director | Sep 16, 2025 | Option exercise | +13,333 | $8.32 | $110.93K | 38,333 |
| Alan W. Dunton Director | Sep 12, 2025 | Sale | −10,000 | $13.13 | $131.30K | 40,250 |
| Alan W. Dunton Director | Sep 12, 2025 | Option exercise | +10,000 | $3.55 | $35.50K | 50,250 |
| Joseph Todisco Chief Executive Officer | Sep 12, 2025 | Option exercise | +50,000 | $3.47 | $173.50K | 559,496 |
| Joseph Todisco Chief Executive Officer | Sep 12, 2025 | Sale | −50,000 | $13.00 | $650.00K | 509,496 |
| Elizabeth Hurlburt Chief Operating Officer | Sep 11, 2025 | Sale | −41,121 | $13.08 | $537.86K | 176,990 |
| Elizabeth Hurlburt Chief Operating Officer | Sep 11, 2025 | Option exercise | +41,121 | $1.45 | $59.63K | 218,111 |
| Elizabeth Hurlburt Chief Operating Officer | Sep 9, 2025 | Option exercise | +12,876 | $1.45 | $18.67K | 189,866 |
| Elizabeth Hurlburt Chief Operating Officer | Sep 9, 2025 | Sale | −12,876 | $13.51 | $173.95K | 176,990 |
| Kaufman Beth Zelnick Chief Legal Officer | Sep 9, 2025 | Sale | −400 | $12.82 | $5.13K | 180,418 |
| Kaufman Beth Zelnick Chief Legal Officer | Sep 9, 2025 | Option exercise | +50,000 | $3.30 | $165.00K | 230,418 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dillione Janet Director | Jan 21, 2026 | 10,000 | $68.50K | Jan 21, 2026 | Stock Plan Activity |
| Dunton Alan Director | Dec 30, 2025 | 20,000 | $259.40K | Dec 30, 2025 | Stock Plan Activity |
| Todisco Joseph Officer | Dec 18, 2025 | 30,000 | $359.15K | Dec 18, 2025 | Stock Plan Activity |
| Dillione Janet BOD | Dec 9, 2025 | 34,000 | $408.00K | Dec 9, 2025 | Stock Plan Activity |
| Steven W. Lefkowitz Director | Dec 9, 2025 | 40,000 | $450.40K | Dec 9, 2025 | Open Market Purchase |
| Dillione Janet Director | Nov 24, 2025 | 73,000 | $727.93K | Nov 24, 2025 | Stock Plan Activity |
| Janet Dillione Director | Nov 14, 2025 | 30,000 | $328.20K | Nov 14, 2025 | Purchased |
| Mistry Erin Former Officer | Nov 10, 2025 | 13,543 | $148.72K | Nov 10, 2025 | Stock Plan Activity |
| Mistry Erin Former Officer | Nov 6, 2025 | 13,908 | $152.50K | Nov 6, 2025 | Stock Plan Activity |
| Alan W. Dunton Director | Sep 12, 2025 | 10,000 | $130.95K | Sep 12, 2025 | Stock plan activity |
| Joseph Todisco Officer | Sep 12, 2025 | 50,000 | $648.57K | Sep 12, 2025 | Stock Plan Activity |
| Elizabeth Hurlburt Officer | Sep 9, 2025 | 53,997 | $728.96K | Sep 9, 2025 | Stock Plan Activity |
| Kaufman Beth Zelnick Officer | Sep 9, 2025 | 50,000 | $673.00K | Sep 9, 2025 | Stock Plan Activity |
| Matthew T. David Former Officer | Sep 3, 2025 | 300,000 | $4.35M | Sep 3, 2025 | Stock Plan Activity |
| Elizabeth Hurlburt Officer | Nov 14, 2024 | 140,027 | $1.56M | Nov 14, 2024 | Stock Plan Activity |